Observational database for patients with immune thrombocytopenia in Brest
Observatory of Immunological Thrombopenic Purpura in the Brest Region: Descriptive and Comparative Cross-sectional Study
University Hospital, Brest · NCT06556888
This study is creating a detailed database for people with immune thrombocytopenia at the University Hospital of Brest to help improve understanding and treatment of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | All |
| Sponsor | University Hospital, Brest (other) |
| Locations | 1 site (Brest, Brittany Region) |
| Trial ID | NCT06556888 on ClinicalTrials.gov |
What this trial studies
This study aims to create a comprehensive clinical and biological database for patients diagnosed, treated, and followed for immune thrombocytopenia (ITP) at the University Hospital of Brest. By collecting detailed information on patient demographics, treatment regimens, and clinical outcomes, the study seeks to enhance understanding of ITP and improve patient management. The University Hospital of Brest serves as a regional reference center for hemorrhagic diseases, ensuring a focused approach to this condition. The data collected will be invaluable for future research and treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with immune thrombocytopenia who agree to participate.
Not a fit: Patients with other forms of thrombocytopenia or those under guardianship may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and treatment strategies for patients with immune thrombocytopenia.
How similar studies have performed: While this approach is observational and may not have direct precedents, similar databases have been successful in enhancing understanding of other hematological conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with ITP agree to participate Exclusion Criteria: * Other thrombocythopenia other than ITP * Patients Under guardianship * Patients without national social security
Where this trial is running
Brest, Brittany Region
- Hematology Department - Institute of Oncology and Hematology, University Hospital of Brest — Brest, Brittany Region, France (RECRUITING)
Study contacts
- Principal investigator: Brigitte Pan-Petesch, MD — UHB
- Study coordinator: Brigitte Pan-Petesch, MD
- Email: brigitte.pan-petesch@chu-brest.fr
- Phone: 33298223650
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Immune Thrombocytopenia